Strategic Intellectual Property Insight Platform
See the following -
I.B.M. Using Bits of Watson for Drug Research
Steve Lohr | The New York Times | December 8, 2011
The ingredients that went into the Watson arsenal are steadily finding their way into I.B.M. products. For example, WellPoint, the big health insurer, is trying out a system that uses Watson-style software to reduce redundant medical tests.
- Login to post comments